HBRM

 
Common Stock Alternative Reporting
Pink Current Information
 

OTC Disclosure & News Service

 

Herborium Group's 2014 First Seven Months Sales Surpasses 2013 Annual Sales.

Jul 24, 2014

OTC Disclosure & News Service

-

Fort Lee, New Jersey, July 24, 2014 (GLOBE NEWSWIRE) -- Fort Lee, N.J. July 24, 2014  Herborium® Group, Inc. (OTC Pink: HBRM),  www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all  botanical medicinal products  (Botanical Therapeutics®) that target dermatological problems such as acne, and other health  and wellness concerns in the areas of sexual performance as well as energy  depletion and stress,  reports  that  its sales  for  the  first seven months of 2014  has surpassed the sales realized in the entire  year of 2013.  This reaffirms the present run rate for AcnEase® sales for 2014 to exceed $1 million dollars.

The Company's continuing sales growth is attributed to its consistent and innovative marketing and sales strategy that focus on  parallel US and global market expansion employing a mix of Social Media and educative marketing.  Very successful penetration of AcnEase® in the French market, entry into Spanish speaking markets  with a newly established  Spanish Website,  and reinvigorated sales in the UK  combined with  strong brand building program -provide the foundation for this accelerated growth.

 The company plans to target one more large market this year to support its aggressive growth. 

Herborium remains very optimistic about growing its business, sales and product awareness driven by the steady growth of the AcnEase® brand as well as interest in its three new products: Lasting Pleasure®, Lasting Power® and Lasting Energy®  which are scheduled to enter the market this year.  The Company continues its efforts to decrease costs and to retire debt, thus increasing the Company's ability to secure outside funding with reasonable commercial terms.. 

There is  rising interest in Botanical Therapeutics® among consumers as well as  the financial and medical communities that will serve as a solid foundation for the company's promising future.        

About Herborium Group, Inc.

Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements).  The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage.  Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.

Safe Harbor Statement:  This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties.  The Company's actual future results could materially differ from those discussed.   The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.

Herborium Group, Inc.

Email: InvestorsRelations@Herborium.com

or DrAgnes@Herborium.com

Herborium Group, Inc.

Copyright © 2014 GlobeNewswire. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.